595 related articles for article (PubMed ID: 30349977)
1. Diabetic cardiomyopathy: molecular mechanisms, detrimental effects of conventional treatment, and beneficial effects of natural therapy.
Parim B; Sathibabu Uddandrao VV; Saravanan G
Heart Fail Rev; 2019 Mar; 24(2):279-299. PubMed ID: 30349977
[TBL] [Abstract][Full Text] [Related]
2. TRB3 gene silencing alleviates diabetic cardiomyopathy in a type 2 diabetic rat model.
Ti Y; Xie GL; Wang ZH; Bi XL; Ding WY; Wang J; Jiang GH; Bu PL; Zhang Y; Zhong M; Zhang W
Diabetes; 2011 Nov; 60(11):2963-74. PubMed ID: 21933987
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs and long non-coding RNAs in the pathophysiological processes of diabetic cardiomyopathy: emerging biomarkers and potential therapeutics.
Jakubik D; Fitas A; Eyileten C; Jarosz-Popek J; Nowak A; Czajka P; Wicik Z; Sourij H; Siller-Matula JM; De Rosa S; Postula M
Cardiovasc Diabetol; 2021 Feb; 20(1):55. PubMed ID: 33639953
[TBL] [Abstract][Full Text] [Related]
4. Isosteviol ameliorates diabetic cardiomyopathy in rats by inhibiting ERK and NF-κB signaling pathways.
Tang SG; Liu XY; Ye JM; Hu TT; Yang YY; Han T; Tan W
J Endocrinol; 2018 Jul; 238(1):47-60. PubMed ID: 29720537
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor beta (TGF-β) mediates cardiac fibrosis and induces diabetic cardiomyopathy.
Yue Y; Meng K; Pu Y; Zhang X
Diabetes Res Clin Pract; 2017 Nov; 133():124-130. PubMed ID: 28934669
[TBL] [Abstract][Full Text] [Related]
6. Protection by dimethyl fumarate against diabetic cardiomyopathy in type 1 diabetic mice likely via activation of nuclear factor erythroid-2 related factor 2.
Hu X; Rajesh M; Zhang J; Zhou S; Wang S; Sun J; Tan Y; Zheng Y; Cai L
Toxicol Lett; 2018 May; 287():131-141. PubMed ID: 29408448
[TBL] [Abstract][Full Text] [Related]
7. The Role of Heme Oxygenase 1 in the Protective Effect of Caloric Restriction against Diabetic Cardiomyopathy.
Waldman M; Nudelman V; Shainberg A; Zemel R; Kornwoski R; Aravot D; Peterson SJ; Arad M; Hochhauser E
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31100876
[TBL] [Abstract][Full Text] [Related]
8. Argatroban Attenuates Diabetic Cardiomyopathy in Rats by Reducing Fibrosis, Inflammation, Apoptosis, and Protease-Activated Receptor Expression.
Bulani Y; Sharma SS
Cardiovasc Drugs Ther; 2017 Jun; 31(3):255-267. PubMed ID: 28695302
[TBL] [Abstract][Full Text] [Related]
9. Streptozotocin-induced type II diabetic rat administered with nonobesogenic high-fat diet is highly susceptible to myocardial ischemia-reperfusion injury: An insight into the function of mitochondria.
Ansari M; Gopalakrishnan S; Kurian GA
J Cell Physiol; 2019 Apr; 234(4):4104-4114. PubMed ID: 30191974
[TBL] [Abstract][Full Text] [Related]
10. Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes.
Huynh K; Kiriazis H; Du XJ; Love JE; Jandeleit-Dahm KA; Forbes JM; McMullen JR; Ritchie RH
Diabetologia; 2012 May; 55(5):1544-53. PubMed ID: 22374176
[TBL] [Abstract][Full Text] [Related]
11. Diazoxide preconditioning of endothelial progenitor cells from streptozotocin-induced type 1 diabetic rats improves their ability to repair diabetic cardiomyopathy.
Ali M; Mehmood A; Anjum MS; Tarrar MN; Khan SN; Riazuddin S
Mol Cell Biochem; 2015 Dec; 410(1-2):267-79. PubMed ID: 26359087
[TBL] [Abstract][Full Text] [Related]
12. DDAH2 alleviates myocardial fibrosis in diabetic cardiomyopathy through activation of the DDAH/ADMA/NOS/NO pathway in rats.
Zhu ZD; Ye JM; Fu XM; Wang XC; Ye JY; Wu XR; Hua P; Liao YQ; Xuan W; Duan JL; Li WY; Fu H; Xia ZH; Zhang X
Int J Mol Med; 2019 Feb; 43(2):749-760. PubMed ID: 30569164
[TBL] [Abstract][Full Text] [Related]
13. Effects of resveratrol on regulation on UCP2 and cardiac function in diabetic rats.
Diao J; Wei J; Yan R; Fan G; Lin L; Chen M
J Physiol Biochem; 2019 Feb; 75(1):39-51. PubMed ID: 30225723
[TBL] [Abstract][Full Text] [Related]
14. Irbesartan ameliorates diabetic cardiomyopathy by regulating protein kinase D and ER stress activation in a type 2 diabetes rat model.
Liu X; Xu Q; Wang X; Zhao Z; Zhang L; Zhong L; Li L; Kang W; Zhang Y; Ge Z
Pharmacol Res; 2015 Mar; 93():43-51. PubMed ID: 25617729
[TBL] [Abstract][Full Text] [Related]
15. GCN2 deficiency ameliorates cardiac dysfunction in diabetic mice by reducing lipotoxicity and oxidative stress.
Feng W; Lei T; Wang Y; Feng R; Yuan J; Shen X; Wu Y; Gao J; Ding W; Lu Z
Free Radic Biol Med; 2019 Jan; 130():128-139. PubMed ID: 30389499
[TBL] [Abstract][Full Text] [Related]
16. Low molecular weight fucoidan alleviates cardiac dysfunction in diabetic Goto-Kakizaki rats by reducing oxidative stress and cardiomyocyte apoptosis.
Yu X; Zhang Q; Cui W; Zeng Z; Yang W; Zhang C; Zhao H; Gao W; Wang X; Luo D
J Diabetes Res; 2014; 2014():420929. PubMed ID: 25525607
[TBL] [Abstract][Full Text] [Related]
17. Telmisartan improves cardiac fibrosis in diabetes through peroxisome proliferator activated receptor δ (PPARδ): from bedside to bench.
Chang WT; Cheng JT; Chen ZC
Cardiovasc Diabetol; 2016 Aug; 15(1):113. PubMed ID: 27519769
[TBL] [Abstract][Full Text] [Related]
18. Smad3 Signaling Promotes Fibrosis While Preserving Cardiac and Aortic Geometry in Obese Diabetic Mice.
Biernacka A; Cavalera M; Wang J; Russo I; Shinde A; Kong P; Gonzalez-Quesada C; Rai V; Dobaczewski M; Lee DW; Wang XF; Frangogiannis NG
Circ Heart Fail; 2015 Jul; 8(4):788-98. PubMed ID: 25985794
[TBL] [Abstract][Full Text] [Related]
19. G protein-coupled receptor kinase-2: A potential biomarker for early diabetic cardiomyopathy.
Lai S; Fu X; Yang S; Zhang S; Lin Q; Zhang M; Chen H
J Diabetes; 2020 Mar; 12(3):247-258. PubMed ID: 31680450
[TBL] [Abstract][Full Text] [Related]
20. Rutin alleviates diabetic cardiomyopathy and improves cardiac function in diabetic ApoEknockout mice.
Huang R; Shi Z; Chen L; Zhang Y; Li J; An Y
Eur J Pharmacol; 2017 Nov; 814():151-160. PubMed ID: 28826911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
